Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors

Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors

Background Immune checkpoint inhibitors (CIs) have revolutionized treatment of advanced melanoma, leading to an emerging population of long-term survivors. Survivors’ quality of life (QOL) and symptom burden are poorly understood. We set out to evaluate symptom burden and QOL in patients with advanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael A Postow, Maha Mamoor, Jessica A Lavery, Shrujal S Baxi, Niloufer Khan, Jun J Mao, Lauren J Rogak, Robert Sidlow, Bridgette Thom, Jedd A Wolchok, Deborah Korenstein
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000260.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items